Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Pulse Biosciences, Inc (PLSE) vs Warby Parker Inc. (WRBY)

Pulse Biosciences, Inc and Warby Parker Inc. are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.8B against $3.3B — 1.1× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; Warby Parker Inc. trades at 382×. Warby Parker Inc. grew revenue faster over the last twelve months: 11.0% against −23.3%. Warby Parker Inc. has the higher net margin (0.85% vs −6,755.8%) and the higher return on invested capital (0.98% vs 0.00%). Across the 16 metrics below, Warby Parker Inc. leads on 15 and Pulse Biosciences, Inc on 1.

Valuation

Metric PLSE WRBY Medical Instruments & Supplies median
P/E n/m 381.57 34.17
P/S 3,023.78 3.63 2.83
P/B 36.01 8.45 2.82
Price to free cash flow n/m 152.23 25.69
EV/EBITDA n/m 51.14 16.08
EV/Sales 2,945.94 3.31 3.06
Earnings yield (2.28%) 0.26% (1.84%)
Free cash flow yield (1.71%) 0.66% 0.17%

Profitability

Metric PLSE WRBY Medical Instruments & Supplies median
Gross margin 0.25% 54.68% 54.62%
Operating margin (7,007.76%) 0.17% 1.64%
Net margin (6,755.78%) 0.85% 0.00%
Free cash flow margin (5,180.42%) 2.39% 1.61%
Return on equity (78.49%) 2.06% 0.00%
Return on assets (67.90%) 1.05% 0.00%
Return on invested capital 0.00% 0.98% 0.00%

Growth

Metric PLSE WRBY Medical Instruments & Supplies median
Revenue growth (TTM) (23.25%) 10.99% 9.20%
EPS growth (last fiscal year) (17.39%) 105.88% —
Revenue growth, 5-year CAGR — 17.23% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PLSE WRBY Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 9.63 2.27 2.49
Net debt to EBITDA 1.06 (5.92) 0.83

Dividend

Metric PLSE WRBY Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric PLSE WRBY Medical Instruments & Supplies median
Market cap 3.77b 3.28b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack